Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
<p>Abstract</p> <p>Dysglycaemic disease is one of the most important health issues facing the world in the 21<sup>st </sup>century. Patients with type 2 diabetes and individuals with prediabetes are at risk of developing macrovascular and microvascular complications. Long-term management strategies...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2007-08-01
|
| Ráidu: | Cardiovascular Diabetology |
| Liŋkkat: | http://www.cardiab.com/content/6/1/20 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|